Zobrazeno 1 - 4
of 4
pro vyhledávání: '"63"'
Autor:
Zarnie Lwin, Barbara Ann Miller, Warren P. Mason, Eshetu G. Atenafu, Normand Laperriere, Cynthia Ménard, Ahmed Al-Zahrani, Arjun Sahgal, Derek R. MacFadden
Publikováno v:
Journal of Neuro-Oncology. 115:303-310
Temozolomide (TMZ) during and after radiotherapy (RT) is recommended for patients with newly diagnosed glioblastoma (GBM). We analyzed the adoption of this new standard of care for GBM in an academic cancer centre in Canada and assessed its impact on
Publikováno v:
Journal of neuro-oncology. 119(1)
To determine the outcome of elderly patients with glioblastoma managed with hypofractionated [40 Gray (Gy)] or long-course (60 Gy) radiation therapy (RT). Patients aged60 years diagnosed with WHO grade IV glioma managed with RT between October 2006 a
Autor:
Vineet Punia, Vaios Hatzoglou, Sasan Partovi, Sasan Karimi, Lauren E. Abrey, Lisa M. DeAngelis
Publikováno v:
Journal of neuro-oncology. 111(1)
The incidence of primary central nervous system lymphoma (PCNSL) has increased over the past two decades. The MR imaging appearance of PCNSL plays a central role in the initial diagnosis, management and follow-up of patients. The purpose of this stud
Autor:
Jennie Bahng, Timothy F. Cloughesy, James Roring, Albert Lai, Whitney B. Pope, Phioanh L. Nghiemphu, Suchitra Ananthnarayan
Publikováno v:
Journal of neuro-oncology. 88(3)
Glioblastoma multiforme (GBM) are morphologically heterogeneous tumors, with varying amounts of necrosis, and edema. Previous studies have shown that treatments incorporating the VEGF antibody bevacizumab can reduce edema and tumor burden in GBM. Add